Institut et Haute école de la Santé, La Source   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Lausanne Switzerland (1859)

Organization Overview

First Clinical Trial
2011
NCT01210040
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Institut de Recherche en Sciences de la Sante | Institut de Recherche en Sciences de la Santé | Institut de Recherche en Sciences de la Sante, Burkina Faso | Institut de Recherche en Sciences de la Sante-Direction Regionale de l'Ouest | Institut et Haute Ecole de la Santé la Source | Institut et Haute école de la Santé, La Source | IRSS/Centre Muraz

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Birth Weight (Phase 4)

Elephantiasis (Phase 3)

Elephantiasis, Filarial (Phase 3)

Filariasis (Phase 3)

Infant Nutrition Disorders (Phase 4)

Malaria (Phase 4)

Malaria, Falciparum (Phase 3)

Malnutrition (Phase 4)

Respiratory Tract Infections (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 15
  • # of Trial APIs: 23